Clinical Trials on Vascular Closure in Japan

Total 1104 results

Okayama University

Completed

Effect of Midazolam on White-coat Hypertensive Dental Patients

Transient Hypertension

Japan
Kyowa Kirin Co., Ltd.

Terminated

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Healthy Volunteers | Wet Age-related Macular Degeneration

Japan
National Center of Neurology and Psychiatry, Japan
Nippon Shinyaku Co., Ltd.

Completed

Exploratory Study of NS-065/NCNP-01 in DMD

Duchenne Muscular Dystrophy

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Patients With Essential Hypertension (ESAX-HTN)

Essential Hypertension

Japan
National Center of Neurology and Psychiatry, Japan
Nippon Shinyaku Co., Ltd.

Completed

Exploratory Study of NS-089/NCNP-02 in DMD

Duchenne Muscular Dystrophy

Japan
Takeshi Morimoto

Completed

Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study (ONCO DVT)

Neoplasms | Venous Thrombosis | Anticoagulant

Japan
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.

Neovascular Age-related Macular Degeneration

Japan
Novartis

Completed

SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

Hypertension

Japan
Kumamoto University

Completed

Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration

Age-related Macular Degeneration

Japan
Kyoto University, Graduate School of Medicine

Recruiting

Cohort Study of the Clinical Course of Macular Diseases in Japanese

Macular Disease

Japan
Alnylam Pharmaceuticals

Recruiting

A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

Mild to Moderate Hypertension

Japan
Aichi Gakuin University

Unknown

Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells

Atherosclerosis

Japan
Ministry of Health, Labour and Welfare, Japan
Japan Cardiovascular Research Foundation

Unknown

Hypertension Control Based on Home Blood Pressure

Hypertension

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition

Hypertension

Japan
Takashi Kubo, MD
Daiichi Sankyo, Inc.

Unknown

Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention (COCOA)

Coronary Disease

Japan
Takeda

Completed

A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet

Hypertension

Japan
Kyushu University

Completed

Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial (COMFORT)

Hypertension

Japan
Suzuka Hospital
Nagoya University

Unknown

The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy

Cardiomyopathies | Duchenne Muscular Dystrophy

Japan
Novo Nordisk A/S

Completed

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

Healthy Volunteers | Atherosclerotic Cardiovascular Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

Japan
Medtronic Endovascular

Completed

TurboHawk™ Japan Trial in Patients With PAD

Peripheral Arterial Disease

Japan
Bayer
Janssen Research & Development, LLC

Completed

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE) (JPMS-XAR-VTE)

Venous Thromboembolism

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

Japan
Santen Pharmaceutical Co., Ltd.

Completed

DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%

Ocular Hypertension | Open Angle Glaucoma

Japan
Kurume University

Completed

Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation

Atherosclerosis

Japan
Santen Pharmaceutical Co., Ltd.

Completed

DE-111 Against Timolol Ophthalmic Solution 0.5%

Ocular Hypertension | Open Angle Glaucoma

Japan
Kurashiki Central Hospital

Unknown

Bifurcation Stenting Using 2 Link Stent Nobori Versus 3 Link Stent Xience (BEGIN)

Coronary Stenosis

Japan
Kagawa University
Novartis Pharmaceuticals

Completed

Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema

Diabetic Macular Edema

Japan
Stella Pharma Corporation
Cancer Intelligence Care Systems, Inc.

Recruiting

A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA

Unresectable Angiosarcoma

Japan
Hyogo College of Medicine

Withdrawn

Relationship Between Pressure and Flow Velocity on Coronary Physiology

Coronary Stenosis

Japan
Showa University

Completed

The Effect of a Blue Light Filtering IOL

to Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract Surgery

Japan
Kurume University

Completed

Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle

Atherosclerosis

Japan
Sohag University

Unknown

Evaluation of Anti-neutrophil Cytoplasm Antibodies Test

Immunological Testing in Small-vessel Vasculitis

Japan
Daiichi Sankyo Co., Ltd.

Completed

A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Venous Thromboembolism | Prevention

Japan
Tottori University Hospital

Completed

Effects of Pioglitazone in Hypertensive Patients

Hypertension | Insulin Resistance

Japan
Kyushu University
Japan Agency for Medical Research and Development; Ministry of Health, Labour...

Active, not recruiting

Randomized Phase IIb Trial of DVC1-0101

Peripheral Arterial Disease | Intermittent Claudication

Japan
Kyoto University, Graduate School of Medicine

Active, not recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study (STOPDAPT-3)

Acute Coronary Syndrome

Japan
Kyorin University

Completed

Foveal Cone Outer Segment Resumption to Predict Visual Recovery After Macular Hole Surgery

Macular Holes

Japan
Sanofi

Completed

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

Abdominal Neoplasms

Japan
Kyorin University

Completed

Observation of Recovery of Foveal Cone Microstructures After Macular Hole Surgery

Macular Holes

Japan
Takeshi Morimoto

Completed

Carvedilol Post-intervention Long-term Administration in Large-scale Trial (CAPITAL-RCT)

Myocardial Infarction

Japan
GlaxoSmithKline

Completed

A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients

Atherosclerosis

Japan
Santen Pharmaceutical Co., Ltd.

Completed

To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

Japan
Kagawa University

Recruiting

Cohort Study of the Clinical Course of Macular Diseases in Kagawa

Macular Disease

Japan
Kyorin University

Completed

Foveal Cone Outer Segment Tips Line Defect in Macular Pseudohole

Macular Psudohole

Japan
Alcon, a Novartis Company

Completed

Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution

Ocular Hypertension | Open-Angle Glaucoma

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

Japan
National Hospital Organization Okayama Medical...
Bayer Yakuhin, Ltd.

Recruiting

THERAPY-HYBRID-BPA Trial

Hypertension, Pulmonary

Japan
Conor Medsystems
Getz Pharma

Terminated

Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety

Coronary Disease

Japan
Daiichi Sankyo, Inc.

Completed

A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment

Hypertension

Japan

3

Subscribe